NYT Current Ratio Analysis
Updated 374h ago·SEC filings & market data
Key Takeaway
The current ratio measures a company's ability to cover short-term obligations with its short-term assets; at 1.58x, NYT has $1.58 in current assets for every $1 of current liabilities.
Sector Performance
64th percentileNYT
1.58x
Sector Median
1.26x
Sector Avg
2.60x
Prior Period
1.60x(Jul 2026)
Deep Analysis
The current ratio measures a company's ability to cover short-term obligations with its short-term assets; at 1.58x, NYT has $1.58 in current assets for every $1 of current liabilities.
This is higher than the sector median of 1.24x, placing the company in the 67th percentile among peers. The metric's year-over-year change is unavailable, but it fell 1.3% quarter-over-quarter from 1.60x to 1.58x, based on the two most recent values. The combination of a solid liquidity level above the sector norm and a slight quarterly decline suggests modest balance-sheet strength with a minor erosion in short-term cushion. This does not point to an immediate liquidity risk, but the downward move bears watching. The metric supports the overall NEUTRAL verdict, as the liquidity position is healthy yet not exceptional, and the trend offers no clear catalyst for a positive or negative outlook.
Frequently Asked Questions
What does the Current Ratio tell investors about NYT?
Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.
How is the Current Ratio calculated?
Current Ratio is calculated as: Current Assets / Current Liabilities.
Learn More About Current Ratio
The Formula
Current Assets / Current Liabilities
Why It Matters
Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.
Master NYT's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full NYT research report →NYT
1.58x
Sector Median
1.26x
Sector Avg
2.60x
How NYT's Current Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.